Bega – Update

Posted on | by Leon Hinde

Bega Cheese is under Algo Engine buy conditions and is a current holding in our ASX model portfolio.

Accumulate within the $5.50 – $5.70 price range.

4/6 Update: Bega has now rallied from Wednesday’s $5.64 low to be trading today at $5.90. Traders – stay long BGA whilst the price action remains above the 10 day average.

Investors – You may choose to simply hold the stock for yield and the likely compound 5 – 9% EPS growth.

IPL – 1H21 Result

Posted on | by Leon Hinde

Incitec Pivot is now under Algo Engine buy conditions.

The company reported 1H21 Sales of $1.72m with underlying EBITDA of $286m. The EBIT miss was primarily driven by Fertilizers and Dyno Americas, with Dyno APAC largely in-line.

Our Option Lab AI technology suggests looking at the following call.

3/6 Buy IPL

Call options are now trading $0.20 to $0.24

Cure ETF – Buy

Posted on | by Leon Hinde

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.

Qube Holdings – Buy

Posted on | by Leon Hinde

Qube Holdings is under Algo Engine buy conditions.

Port volumes for April & May were stronger than analysts expected which adds support to the $3.50 price target for Qube.

Total container movements across Australia’s major ports have increased +11% compared to the same time last year.

China ETF – IZZ

Posted on | by Leon Hinde

ASX:IZZ is under Algo Engine buy conditions. We expect buying interest to increase within the $55 – $60 price range.

Traders may wait for the third factor to align, an upturn in the momentum indicators. Watch for the stochastic to move higher or the price action on the main chart to cross above the 10-day average.

21/5 Buy IZZ

31/5 IZZ remains above the 10 day average.

Cure ETF – Buy

Posted on | by Leon Hinde

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.